A research team led by Prof. Sun Cheng from the University of Science and Technology of China (USTC), in collaboration with researchers from the Agency for Science, Technology and Research and Chinese Academy of Agricultural Sciences, has successfully developed a novel spatial immune-based hepatocellular carcinoma (HCC) recurrence risk prediction platform.
Go to Source
https://medicalxpress.com/rss-feed/